tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XERS Stock Latest News

American Regent launches Gvoke VialDx
The FlyAmerican Regent launches Gvoke VialDx
1M ago
XERS
Xeris Biopharma announces Orange Book listing of U.S. patent for Recorlev
PremiumThe Fly
Xeris Biopharma announces Orange Book listing of U.S. patent for Recorlev
1M ago
XERS
Xeris Pharmaceuticals Reports Record Revenue and Growth
PremiumCompany Announcements
Xeris Pharmaceuticals Reports Record Revenue and Growth
2M ago
XERS
Xeris Pharmaceuticals: Undervalued Growth Potential Driven by Recorlev and XP-8121
PremiumRatings
Xeris Pharmaceuticals: Undervalued Growth Potential Driven by Recorlev and XP-8121
2M ago
XERS
Xeris Biopharma assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Xeris Biopharma assumed with a Buy at H.C. Wainwright
2M ago
XERS
Xeris Biopharma price target raised to $8 from $7 at Oppenheimer
PremiumThe FlyXeris Biopharma price target raised to $8 from $7 at Oppenheimer
2M ago
XERS
Xeris Biopharma Reports Strong Q2 2025 Results
Premium
Company Announcements
Xeris Biopharma Reports Strong Q2 2025 Results
2M ago
XERS
Xeris Pharmaceuticals Completes Promising Phase 2 Study on Hypothyroidism Treatment
Premium
Company Announcements
Xeris Pharmaceuticals Completes Promising Phase 2 Study on Hypothyroidism Treatment
3M ago
XERS
Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting
4M ago
8K
XERS
Xeris Pharmaceuticals Hosts Analyst and Investor Day
PremiumCompany Announcements
Xeris Pharmaceuticals Hosts Analyst and Investor Day
4M ago
8K
XERS
Xeris Biopharma to hold analyst and investor day
PremiumThe Fly
Xeris Biopharma to hold analyst and investor day
4M ago
XERS
Positive Outlook and Strategic Advancements Drive Buy Rating for Xeris Pharmaceuticals
PremiumRatings
Positive Outlook and Strategic Advancements Drive Buy Rating for Xeris Pharmaceuticals
5M ago
XERS
Xeris Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating
PremiumRatingsXeris Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating
5M ago
XERS
Xeris Biopharma price target raised to $7 from $6 at Oppenheimer
Premium
The Fly
Xeris Biopharma price target raised to $7 from $6 at Oppenheimer
5M ago
XERS
Xeris Biopharma Reports Strong Q1 2025 Growth
Premium
Company Announcements
Xeris Biopharma Reports Strong Q1 2025 Growth
5M ago
XERS
Xeris Pharmaceuticals Reports Strong Earnings and Growth
PremiumCompany Announcements
Xeris Pharmaceuticals Reports Strong Earnings and Growth
5M ago
XERS
Xeris Biopharma reports Q1 EPS (6c), consensus (4c)
PremiumThe Fly
Xeris Biopharma reports Q1 EPS (6c), consensus (4c)
5M ago
XERS
Xeris Pharmaceuticals Announces Board Changes with New Appointment
PremiumCompany Announcements
Xeris Pharmaceuticals Announces Board Changes with New Appointment
6M ago
8K
XERS
FDA approves Xeris Biopharma’s sNDA of Gvoke VialDx as gastro diagnostic aid
PremiumThe Fly
FDA approves Xeris Biopharma’s sNDA of Gvoke VialDx as gastro diagnostic aid
6M ago
XERS
Xeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
PremiumMarket NewsXeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
7M ago
XERS
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
Premium
Company Announcements
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
7M ago
XERS
Xeris Biopharma price target raised to $6 from $5 at Leerink
Premium
The Fly
Xeris Biopharma price target raised to $6 from $5 at Leerink
7M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >